
    
      Entry criteria：1. Age 18 years and above. 2. male or female. 3. Diagnosed as chronic HBV
      infection (HBsAg positive) 4.Ability to sign informed consent.

      Exclusion criteria：Patients who disagree to participate in the trial.

      After the informed consent was signed, the quantitative data of the previous surface antigen
      or HBV DNA titer was collected during the return visit. 4 ml of venous blood was collected on
      the same day or the remaining serum from the surface antigen or hepatitis B quantitative test
      was collected for the detection of hepatitis D antibody and/or the quantitative detection of
      hepatitis D RNA.

      After statistical analysis, calculate the hepatitis D infection status in China.
    
  